Hepatic biliary adenofibroma (BAF) is a rare benign bile duct neoplasm that has garnered increasing attention due to its potential role as a precursor lesion for intrahepatic cholangiocarcinoma (iCCA) ...

A family is backing research into a new gene therapy for a rare liver condition, after their daughter's shock diagnosis.

A family is backing research into a new gene therapy for a rare liver condition, after their daughter's shock diagnosis.

Researchers from Universidad del País Vasco and affiliated organizations presented data from a study that aimed to ...

Mirum Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year-end 2024 and provided a business update. "2024 was another year of significant growth and accomplishments ...

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...

An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.

Intrahepatic cholangiocarcinoma (iCCA) can originate from the large bile duct group (segment bile ducts and area bile ducts), ...

Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and ...

The global biliary stent market was valued at approximately USD 394.5 million in 2022 and is projected to grow at a healthy CAGR of over 5.5% during the forecast period from 2023 ...